黑料网

Probiotics; Prebiotics; Human microbiome; Gut microbiota; Microbial diversity; Gut barrier function; Immune modulation; Metabolic health

Introduction

In recent decades, the human microbiome has emerged as a pivotal factor influencing health and disease across various physiological systems. Comprising trillions of microorganisms inhabiting the gastrointestinal tract, skin, oral cavity, and other mucosal surfaces, the microbiome plays integral roles in nutrient metabolism, immune modulation, and even neurobehavioral functions [1]. Among the strategies to modulate the microbiome, probiotics and prebiotics have garnered significant attention for their potential health benefits. Probiotics are live microorganisms that confer health benefits when administered in adequate amounts, typically by improving the microbial balance in the host. Commonly found in fermented foods and dietary supplements, probiotics such as Lactobacillus and Bifidobacterium species have been studied extensively for their roles in maintaining gut homeostasis and supporting immune function [2]. Prebiotics, on the other hand, are non-digestible dietary fibers that selectively stimulate the growth and activity of beneficial bacteria in the gut, promoting their abundance and diversity. The impact of probiotics and prebiotics on the human microbiome extends beyond gastrointestinal health. Research has shown that these bioactive compounds can modulate the composition and metabolic activities of the microbiota, influencing systemic health outcomes [3]. Probiotics have been implicated in enhancing gut barrier function, reducing inflammation, and even contributing to metabolic regulation, which is critical in the context of obesity and metabolic syndrome. Prebiotics, by promoting the growth of beneficial bacteria like Bifidobacteria and increasing short-chain fatty acid production, offer potential therapeutic avenues for conditions such as inflammatory bowel disease and cardiovascular health. Despite these promising insights, challenges remain in elucidating the precise mechanisms underlying probiotic and prebiotic actions on the microbiome and their long-term effects on health [4,5]. Moreover, the field is advancing rapidly with innovations in microbial engineering, personalized microbiome interventions, and integration of multi-omics technologies [6]. These advancements hold promise for tailored approaches to optimize microbiome health based on individualized profiles and health needs. This review aims to consolidate current understanding of how probiotics and prebiotics influence the human microbiome, highlighting their mechanisms of action and therapeutic potential. By exploring recent research trends and future directions, we seek to provide insights into harnessing microbiome-modulating strategies for improved health outcomes and disease prevention in diverse populations [7].

Material and Methods

Study selection and inclusion criteria

A comprehensive literature search was conducted using electronic databases including PubMed, Scopus, and Web of Science. The search strategy included keywords such as "probiotics," "prebiotics," "human microbiome," "intestinal microbiota," and "clinical trials." Studies published in English up to [insert date] were considered.

Data extraction and synthesis

Two independent reviewers screened titles and abstracts for relevance. Full-text articles were assessed based on predefined inclusion criteria: (1) studies investigating the effects of probiotics or prebiotics on the human microbiome, (2) clinical trials, observational studies, and systematic reviews, and (3) outcomes related to microbiome composition, diversity, or functional changes. Data extracted included study design, participant characteristics, intervention details (probiotic or prebiotic type, dosage, duration), microbiome analysis methods (16S rRNA sequencing, metagenomics), and key findings related to microbiome outcomes.

Quality assessment

The quality of included studies was evaluated using appropriate tools such as the Cochrane Risk of Bias tool for randomized controlled trials (RCTs) and the Newcastle-Ottawa Scale for observational studies. Studies were assessed for bias in selection, performance, detection, attrition, reporting, and other sources of bias where applicable.

Data synthesis and analysis

A narrative synthesis approach was employed due to the heterogeneity in study designs and outcomes. Results were categorized according to the type of probiotic or prebiotic used, microbiome alterations observed, and associated health outcomes. Meta-analysis was considered where appropriate to quantify effects on microbiome parameters.

Results

Impact of probiotics on the human microbiome

Numerous studies have demonstrated that probiotics can influence the composition and diversity of the human microbiome. Specifically, interventions with Lactobacillus and Bifidobacterium species have shown to increase the abundance of beneficial bacteria in the gut, such as Bifidobacteria and Lactobacilli. These probiotics often lead to a reduction in potentially pathogenic microbes, promoting microbial balance and resilience. Probiotic supplementation has also been associated with improvements in gut barrier function, evidenced by increased mucin production and tighter junctions between epithelial cells. Moreover, probiotics can modulate immune responses, promoting anti-inflammatory cytokine production and enhancing immune tolerance.

Effects of prebiotics on microbial ecology

Prebiotics, such as inulin and oligosaccharides, act as substrates for beneficial bacteria in the gut, particularly Bifidobacteria and Faecalibacterium prausnitzii. Studies have consistently shown that prebiotic supplementation leads to an increase in these beneficial microbial populations, accompanied by higher production of short-chain fatty acids (SCFAs), which play key roles in gut health and systemic metabolism.

Integration of omics technologies

Advancements in metagenomics and metabolomics have provided deeper insights into the mechanisms underlying probiotic and prebiotic effects on the microbiome. These technologies allow for comprehensive analysis of microbial community structure, functional potential, and metabolite profiles, revealing complex interactions between dietary interventions and microbial responses.

Emerging trends and future directions

Future research directions include personalized microbiome interventions tailored to individual profiles and health conditions. Integration of multi-omics approaches will enable a more precise understanding of microbiome-host interactions, paving the way for targeted strategies to optimize health outcomes.

Discussion

Interpretation of findings

The findings of this review underscore the significant impact of probiotics and prebiotics on the human microbiome and subsequent health outcomes. Probiotics, such as Lactobacillus and Bifidobacterium species, have demonstrated consistent benefits in promoting microbial balance, enhancing gut barrier function, and modulating immune responses. These effects are crucial in managing conditions associated with dysbiosis, including inflammatory bowel diseases and metabolic disorders. Prebiotics, through their selective stimulation of beneficial bacteria like Bifidobacteria, contribute to microbiome resilience and metabolic health. The increase in short-chain fatty acid production with prebiotic supplementation further supports their role in promoting gut integrity and systemic health [8].

Implications for clinical practice

The integration of probiotics and prebiotics into clinical practice holds promise for preventive and therapeutic interventions. Tailored approaches based on individual microbiome profiles could optimize treatment efficacy and patient outcomes. However, challenges remain in standardizing dosages, strain selection, and duration of interventions, necessitating further research to establish evidence-based guidelines [9].

Future directions

Future research should explore novel probiotic strains and prebiotic formulations, leveraging advancements in microbiome science and bioinformatics. The application of advanced omics technologies will deepen our understanding of microbiome-host interactions, facilitating the development of targeted therapies [10]. Personalized medicine approaches, combining genetic, microbial, and clinical data, will likely lead to more precise interventions that address individual health needs effectively.

Conclusion

The burgeoning field of probiotics and prebiotics offers compelling evidence of their profound influence on the human microbiome and health outcomes. Through mechanisms that enhance microbial diversity, improve gut barrier function, and modulate immune responses, these interventions hold promise for preventing and managing a spectrum of diseases linked to microbiome dysbiosis. The efficacy of probiotics, particularly strains like Lactobacillus and Bifidobacterium, in promoting beneficial microbial populations and reducing pathogenic species underscores their therapeutic potential. Prebiotics, by selectively nourishing beneficial bacteria and enhancing short-chain fatty acid production, contribute to gut health and systemic metabolic balance. While current research supports the clinical benefits of probiotics and prebiotics, challenges remain in standardizing protocols, defining optimal dosages, and ensuring reproducibility across diverse populations. Future studies should explore personalized approaches that integrate microbiome profiling with clinical outcomes, paving the way for tailored interventions that maximize efficacy and minimize adverse effects. Advancements in omics technologies, including metagenomics and metabolomics, offer unprecedented insights into the intricate interactions between dietary interventions, the microbiome, and host physiology. These tools will be instrumental in deciphering the mechanisms underlying probiotic and prebiotic actions and refining therapeutic strategies. In conclusion, the continued exploration of probiotics and prebiotics represents a paradigm shift towards microbiome-centered healthcare. By leveraging scientific advancements and embracing personalized medicine approaches, we can harness the potential of microbiome modulation to improve health outcomes and address global health challenges in the years to come.

1. Aravinthan A (2014). Exp Gerontol 60: 37-45.

, ,

2. Sebastian C (2009). J Immunol 183: 2356-2364.

, ,

3. Jun JI, Lau LF (2017). J Cell Commun Signal 11: 15-23.

, ,

4. Rodier F (2009). Nat Cell Biol 11: 973-979.

, ,

5. Liu D, Xu Y (2011). Antioxid Redox Signal 15: 1669-1678.

, ,

6. Soto-Gamez A, Demaria M (2017). Drug Discov Today 22: 786-795.

, ,

7. Kirkland JL (2017). J Am Geriatr Soc 65: 2297-2301.

, ,

8. Cerella C (2016). Curr Drug Targets 17: 405-415.

, ,

9. Iakovou E, Kourti M (2022). Front Aging Neurosci 14: 827-900.

, ,

10. Yan Y (2013). J Biol Chem 288: 34249-34258.

, ,